Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Chlorhydrate de vancomycine pour injection

Covered
  • Active ingredient(s):
    vancomycin hydrochloride
  • Manufactured by:
    Hikma Canada Limited (Hikma)
  • Strength and dosage form:
    • Intravenous or Perfusion Powder 1 g DIN : 2543982
    • Intravenous or Perfusion Powder 500 mg DIN : 2543974

Nat-Abiraterone

Exceptional medication

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114437
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114435

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114436
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114434

Mar-Afatinib

Exceptional medication
  • Active ingredient(s):
    afatinib dimaleate
  • Manufactured by:
    Marcan Pharmaceuticals Inc. (Marcan)
  • Strength and dosage form:
    • Tablet 20 mg DIN : 2517019
    • Tablet 30 mg DIN : 2517027
    • Tablet 40 mg DIN : 2517035

Bimzelx

Exceptional medication
  • Active ingredient(s):
    bimekizumab (plaque psoriasis)
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 160 mg/mL (1 mL) DIN : 2525267
    • Subcutaneous Injectable Solution syringe 160 mg /mL (2 mL) DIN : 2553619
    • Subcutaneous Injectable Solution (pen) 160 mg/mL (1 mL) DIN : 2525275
    • Subcutaneous Injectable Solution (pen) 160 mg /mL (2 mL) DIN : 2553627

JAMP Cabergoline

Exceptional medication
  • Active ingredient(s):
    cabergoline
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 0.5 mg DIN : 2549611

AG-Gliclazide MR

Covered
  • Active ingredient(s):
    gliclazide
  • Manufactured by:
    Angita Pharma Inc. (Angita)
  • Strength and dosage form:
    • Long-Action Tablet 30 mg DIN : 2483300
    • Long-Action Tablet 60 mg DIN : 2483319

Ixifi

Exceptional medication
  • Active ingredient(s):
    infliximab
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2523191

Remdantry

Exceptional medication
  • Active ingredient(s):
    infliximab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2419475
Page 459 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.